Asia presents huge commercial opportunity to the global pharma market. However this potential can only be realized with successful regulatory approval.
Topics
- Multiple influences on regulatory approval for clinical trials and marketing authorization
- Strategies for lifecycle management including IP, regulatory and drug delivery approaches
- Threats facing intellectual property and products in emerging markets and strategies to protect your IP, products and data exclusivity
- Strategies to optimize communication with health authorities
Who should Attend
Attendees from Pharmaceutical / Generics / Biopharmaceuticals companies, Regulatory authorities (government) & Ministry of Health, Clinical Research Organizations / Consultancies and Medical Devices / Diagnostics Companies.
